Trimi Health Review

Our assessment

Trimi publishes annual-plan rates for semaglutide and tirzepatide, says prices stay flat across doses, and advertises service in all 50 states. The reviewed treatments page, FAQ and cost guide do not publish a month-to-month rate. Its comparison of rival providers is seller-authored marketing; confirm competing prices at their sources.

The gap between the two drugs is unusually small

Across this category, tirzepatide almost always costs meaningfully more than semaglutide. At Trimi the two sit close together.

That matters if you start on semaglutide and may want to switch. At most sellers that switch carries a price increase. Here it is a small step.

Both prices assume you commit to a year

Trimi's published figures are annual-plan rates. That condition is printed beside the numbers rather than hidden, and the site is consistent about it from page to page.

What's missing is the alternative. No month-to-month rate appears on the treatments page, the FAQ or the cost guide. So you can't price a shorter commitment before starting an intake.

An annual commitment can be significant for someone starting treatment. Confirm whether payment is upfront or periodic, and ask how cancellation, refunds and unused medication are handled before enrolling.

What the price is stated to include

Trimi says the rate holds flat across dose levels and covers free shipping, unlimited provider messaging and ongoing dose adjustments.

Flat dosing is the more valuable half. Titrate upward and you are not walking into a price increase, which isn't true at every seller.

Trimi also names the clinician network behind its prescriptions rather than describing it in general terms. That is more specific than most of this field, though a clinical network isn't a pharmacy.

Trimi publishes a table ranking its competitors

Trimi runs a cost guide that names rival providers, prints figures for them, and concludes that Trimi is the cheapest legitimate option.

At least one competitor rate in that table sits well above what the competitor advertises on its own site today. The gap is large enough to change which provider looks cheaper.

None of that says anything about Trimi's medication. It does say something about the source. A seller's table of its rivals is marketing, and it shouldn't be used as a price reference for anyone but Trimi.

What Trimi doesn't publish

Trimi doesn't name the compounding pharmacy that fills an order. The clinical network is named; the pharmacy is not.

No registered legal entity appears anywhere either. The brand is used throughout the terms without a company name behind it, which is thinner than most sellers offer.

Trimi does publish an unusually large library of cost, comparison and dosing material. Volume of content is not the same as telling you who you are buying from.